D'Amico AV, Whittington R, Malkowicz S, et al. Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer. JAMA.1998;280(11):969-974. doi:10.1001/jama.280.11.969.

Rodrigues G, Warde P, Pickles T, et al. Pre-treatment risk stratification of prostate cancer patients: A critical review. Canadian Urological Association Journal. 2012;6(2):121-127. doi:10.5489/cuaj.11085.

Moul JW. The Evolving Definition of Advanced Prostate Cancer. Reviews in Urology. 2004;6(Suppl 8):S10-S17

Boorjian SA, Karnes RJ, Rangel LJ. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol. 2008 Apr;179(4):1354-60; discussion 1360-1. Epub 2008 Mar 4.

Hernandez DJ, Nielsen ME, Han M. Contemporary evaluation of the D'amico risk classification of prostate cancer. Urology. 2007 Nov;70(5):931-5.

Dr. Anthony D'Amico

D'Amico Risk Classification for Prostate Cancer

gleason

stage

Assesses 5 year risk of treatment failure based on clinical factors.

Assesses 5 year failure of prostate CA treatment failure.

D'Amico Classification

The D'Amico Risk Classification for Prostate Cancer assesses 5 year failure of treatment based on clinical factors.

Gleason Score

PREVAIL Model for Prostate Cancer

Prostate Tumor Volume

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function